These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6164030)

  • 1. Vasodilation and the etiology of diabetic retinopathy: a new model.
    Wolbarsht ML; Landers MB; Stefansson E
    Ophthalmic Surg; 1981 Feb; 12(2):104-7. PubMed ID: 6164030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model.
    Wolbarsht ML; Landers MB
    Ophthalmic Surg; 1980 Apr; 11(4):235-45. PubMed ID: 6155650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygenation and vasodilatation in relation to diabetic and other proliferative retinopathies.
    Stefansson E; Landers MB; Wolbarsht ML
    Ophthalmic Surg; 1983 Mar; 14(3):209-26. PubMed ID: 6190118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Microcirculation disturbances at the onset of diabetic retinopathy. New therapeutic procedures? (author's transl)].
    Jütte A; Deufrains A; Dietze U
    Klin Monbl Augenheilkd; 1980 Jul; 177(1):1-6. PubMed ID: 7005511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What is the etiology of diabetic retinopathy?].
    Wiedemann P
    Ophthalmologe; 1993 Oct; 90(5):426-33. PubMed ID: 8219625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of light-flicker-induced retinal vasodilation and retinal vascular caliber measurements in diabetes.
    Nguyen TT; Kawasaki R; Kreis AJ; Wang JJ; Shaw J; Vilser W; Wong TY
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5609-13. PubMed ID: 19643973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of the osmotic pressure of the blood in the pathogenesis of diabetic changes in the retina].
    Zapuskalov IV; Filippova SV; Shilova OG; Krivosheina OI
    Vestn Oftalmol; 2000; 116(2):32-4. PubMed ID: 11055223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of flickering light on the retinal vessels in diabetic patients.
    Mandecka A; Dawczynski J; Blum M; Müller N; Kloos C; Wolf G; Vilser W; Hoyer H; Müller UA
    Diabetes Care; 2007 Dec; 30(12):3048-52. PubMed ID: 17728481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.
    Tawfik A; Sanders T; Kahook K; Akeel S; Elmarakby A; Al-Shabrawey M
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):878-84. PubMed ID: 18806296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinopathy of prematurity: a new look at an old disease.
    Wolbarsht ML; George GS; Shearin WA; Kylstra JA; Landers MB
    Ophthalmic Surg; 1983 Nov; 14(11):919-24. PubMed ID: 6197686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
    Gendron RL; Good WV; Adams LC; Paradis H
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of vascular permeability in diabetic retinopathy.
    Antonetti DA; Lieth E; Barber AJ; Gardner TW
    Semin Ophthalmol; 1999 Dec; 14(4):240-8. PubMed ID: 10758225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological approach to diabetic retinopathy.
    De La Cruz JP; González-Correa JA; Guerrero A; de la Cuesta FS
    Diabetes Metab Res Rev; 2004; 20(2):91-113. PubMed ID: 15037985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introductory comments for session V "neovasculogenesis" presented at the fifth symposium, the International Society on Metabolic Eye Disease October 24-26, 1982.
    Waitzman MB
    Metab Pediatr Syst Ophthalmol; 1983; 7(2):71-4. PubMed ID: 6197603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal vessel oxygen saturation under flicker light stimulation in patients with nonproliferative diabetic retinopathy.
    Hammer M; Heller T; Jentsch S; Dawczynski J; Schweitzer D; Peters S; Schmidtke KU; Müller UA
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4063-8. PubMed ID: 22589440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
    Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Caldwell RW
    Diabetes Metab Res Rev; 2003; 19(6):442-55. PubMed ID: 14648803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor and retinal neovascularisation: a new therapeutic approach for diabetic retinopathy.
    Favard C; Ortega N; Bayard F; Plouet J
    Diabetes Metab; 1996 Jul; 22(4):268-73. PubMed ID: 8767174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis of diabetic retinopathy].
    Dhermy P; Toussaint D
    Bull Soc Belge Ophtalmol; 1980; (188-189):73-85. PubMed ID: 7248656
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of insulin-like growth factor I in the development of diabetic retinopathy].
    Gacka M; Adamiec J
    Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.